Data Query
XBI
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Asset Value: | Change: | Change: |
USD 109.93 | USD 0.98 | 0.89% |
| Price | Change: | Change: |
USD 110.03 | USD 1.08 | 0.98% |
The investment seeks to provide investment results that, before fees and expenses, correspond to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. The fund employs a replication strategy in seeking to track the performance of the S&P Biotechnology Select Industry Index. It generally invests substantially all, but at least 80%, of total assets in the securities comprising the index. The fund may invest in equity securities that are not included in the index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. It is non-diversified.
Holdings
| Top 10 Holdings | |
| NPS Pharmaceuticals Inc | 3.55% |
| Vertex Pharmaceuticals | 3.16% |
| Theravance, Inc. | 2.96% |
| Alkermes PLC | 2.91% |
| Biogen Idec Inc | 2.76% |
| Isis Pharmaceuticals | 2.75% |
| Regeneron Pharmaceuticals, Inc. | 2.70% |
| Seattle Genetics, Inc. | 2.59% |
| Acorda Therapeutics, Inc. | 2.52% |
| Aegerion Pharmaceuticals, Inc. | 2.47% |
| Weighting | 28.37% |
| As of 04/30/2013 | |
Holdings - Country Allocation |
Download Adobe Flash Player to view this page
| Holdings - Sector Breakdowns |
Download Adobe Flash Player to view this page
Historical NAV Performance (%)
1-Day | 1-Week | 1-Mo | 3-Mo | YTD | 1-Yr |
0.89 | 2.61 | 5.94 | 11.32 | 20.41 | 30.43 |
| Cumulative | |||||
2012 | 2011 | 2010 | 2009 | 3 Yr* | 5 Yr* |
32.69 | 5.26 | 17.6 | 0.17 | 20.69 | 13.99 |
| Annual/Annualized | |||||
Portfolio & Management
| Fundamentals | |
| Mean Market Cap: | 2,919.70 |
| P/B Ratio: | 6.61 |
| Dividend Yield (% p.a): | 0.23 |
| Sharpe Ratio 3Yr: | 0.96 |
| r-Squared (3 Yr): | 59.41 |
| Std Dev 3 Year: | 22.16 |
| Alpha: | 10.51 |
| Beta: | 1.02 |
| Dividend Frequency: | Quarterly |
| Portfolio Characteristics | |
| Assets Under Management: | 846,717,390 |
| Exp Ratio: | 0.35 |
| Number of Holdings: | 52 |
| Management | |
| Issuing Company: | SPDR State Street Global Advisors |
| Inc Date: | 2006-01-31 |
| Trading Symbols: | XBI |
| Trading & Liquidity | |
| Spread: | 0.084 |
| % Spread: | 0.0008 |
| Average Daily Dollar Volume: | 11,640,787 |
| Average Daily Share Volume: | 106,432 |
Related Articles
| Related Articles | |
The content on IndexUniverse.com and related sites is for informational purposes only. It is not designed to be used by investors in making specific investment decisions. The content is not intended as advice or recommendation.
© 2013 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
